Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bown

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pathology|July 31, 2002
Acute lymphoblastic leukaemia of the L3 subtype in adults in the Northern health region of England 1983-99M R Velangi, M M Reid, N Bown, et al.
Medical and Pediatric Oncology|July 24, 2001
Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastomaM Lastowska, N Van Roy, N Bown, et al.
Genes, Chromosomes & Cancer|September 17, 2013
Gain of 1q is a marker of poor prognosis in Wilms' tumorsH Segers, M M van den Heuvel-Eibrink, R D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumorsM Lastowska, C Cullinane, S Variend, et al.
Leukemia|January 21, 2006
Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemiaR N Sanderson, P R E Johnson, A V Moorman, et al.
Leukemia|November 22, 2012
Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusionE De Braekeleer, N Douet-Guilbert, P Guardiola, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
The New England Journal of Medicine|June 24, 1999
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastomaN Bown, S Cotterill, M Lastowska, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 6, 2016
The clinical utility of genetic testing of tissues from pregnancy lossesC A Waterman, P Batstone, N Bown, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pathology|July 31, 2002
Acute lymphoblastic leukaemia of the L3 subtype in adults in the Northern health region of England 1983-99M R Velangi, M M Reid, N Bown, et al.
Medical and Pediatric Oncology|July 24, 2001
Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastomaM Lastowska, N Van Roy, N Bown, et al.
Genes, Chromosomes & Cancer|September 17, 2013
Gain of 1q is a marker of poor prognosis in Wilms' tumorsH Segers, M M van den Heuvel-Eibrink, R D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumorsM Lastowska, C Cullinane, S Variend, et al.
Leukemia|January 21, 2006
Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemiaR N Sanderson, P R E Johnson, A V Moorman, et al.
Leukemia|November 22, 2012
Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusionE De Braekeleer, N Douet-Guilbert, P Guardiola, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
The New England Journal of Medicine|June 24, 1999
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastomaN Bown, S Cotterill, M Lastowska, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 6, 2016
The clinical utility of genetic testing of tissues from pregnancy lossesC A Waterman, P Batstone, N Bown, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Pageof 8